SEARCH:   Advanced

This Article Full Text Full Text (PDF) Supplemental PDF Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Morse, H. C. Articles by Ward, J. M. Search for Related Content PubMed PubMed Citation Articles by Morse, H. C., III Articles by Ward, J. M. Related Collections Neoplasia Social Bookmarking                   What's this?  Previous Article  |  Table of Contents  |  Next Article  Blood, 1 July 2002, Vol. 100, No. 1, pp. 246-258 NEOPLASIA Bethesda proposals for classification of lymphoid neoplasms in mice Herbert C. Morse III, Miriam R. Anver, Torgny N. Fredrickson, Diana C. Haines, Alan W. Harris, Nancy L. Harris, Elaine S. Jaffe, Scott C. Kogan, Ian C. M. MacLennan, Paul K. Pattengale, and Jerrold M. Ward From the Laboratory of Immunopathology, National Institute of Allergy and Infectious Diseases, the Hematopathology Section, Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD; the Pathology/Histotechnology Laboratory, SAIC-Frederick, the Veterinary and Tumor Pathology Section, Center for Cancer Research, National Cancer Institute at Frederick, National Institutes of Health, Frederick, MD; the Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia; the Department of Pathology, Massachusetts General Hospital, Boston, MA; the Department of Laboratory Medicine, University of California, San Francisco; Children's Hospital of Los Angeles, CA; and the University of Birmingham Medical School, Birmingham, United Kingdom. A consensus system for classification of mouse lymphoid neoplasms according to their histopathologic and genetic features has been an elusive target for investigators involved in understanding the pathogenesis of spontaneous cancers or modeling human hematopoietic diseases in mice. An international panel of scientists with expertise in mouse and human hematopathology joined with the hematopathology subcommittee of the Mouse Models for Human Cancers Consortium to develop criteria for definition and classification of these diseases together with a standardized nomenclature. The fundamental elements contributing to the scheme are clinical features, morphology, immunophenotype, and genetic characteristics. The resulting classification has numerous parallels to the World Health Organization classification of human lymphoid tumors while recognizing differences that may be species specific. The classification should facilitate communications about mouse models of human lymphoid diseases. © 2002 by The American Society of Hematology.   CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this? This article has been cited by other articles: M. J. Frank, D. W. Dawson, S. J. Bensinger, J. S. Hong, W. M. Knosp, L. Xu, C. E. Balatoni, E. L. Allen, R. R. Shen, D. Bar-Sagi, et al. Expression of sprouty2 inhibits B-cell proliferation and is epigenetically silenced in mouse and human B-cell lymphomas Blood, March 12, 2009; 113(11): 2478 - 2487. [Abstract] [Full Text] [PDF] A. Tuomisto, M. Sund, J. Tahkola, A. Latvanlehto, E.-R. Savolainen, H. Autio-Harmainen, A. Liakka, R. Sormunen, J. Vuoristo, A. West, et al. A Mutant Collagen XIII Alters Intestinal Expression of Immune Response Genes and Predisposes Transgenic Mice to Develop B-Cell Lymphomas Cancer Res., December 15, 2008; 68(24): 10324 - 10332. [Abstract] [Full Text] [PDF] D.-M. Shin, D. J. Shaffer, H. Wang, D. C. Roopenian, and H. C. Morse III NOTCH Is Part of the Transcriptional Network Regulating Cell Growth and Survival in Mouse Plasmacytomas Cancer Res., November 15, 2008; 68(22): 9202 - 9211. [Abstract] [Full Text] [PDF] S. Mori, R. E. Rempel, J. T. Chang, G. Yao, A. S. Lagoo, A. Potti, A. Bild, and J. R. Nevins Utilization of Pathway Signatures to Reveal Distinct Types of B Lymphoma in the E{micro}-myc Model and Human Diffuse Large B-Cell Lymphoma Cancer Res., October 15, 2008; 68(20): 8525 - 8534. [Abstract] [Full Text] [PDF] C. Slape, L. Y. Liu, S. Beachy, and P. D. Aplan Leukemic transformation in mice expressing a NUP98-HOXD13 transgene is accompanied by spontaneous mutations in Nras, Kras, and Cbl Blood, September 1, 2008; 112(5): 2017 - 2019. [Abstract] [Full Text] [PDF] D. J. Castro, W. M. Baird, C. B. Pereira, J. Giovanini, C. V. Lohr, K. A. Fischer, Z. Yu, F. J. Gonzalez, S. K. Krueger, and D. E. Williams Fetal Mouse Cyp1b1 and Transplacental Carcinogenesis from Maternal Exposure to Dibenzo(a,l)pyrene Cancer Prevention Research, July 1, 2008; 1(2): 128 - 134. [Abstract] [Full Text] [PDF] M. N. Lobato, M. Metzler, L. Drynan, A. Forster, R. Pannell, and T. H. Rabbitts Modeling Chromosomal Translocations Using Conditional Alleles to Recapitulate Initiating Events in Human Leukemias J Natl Cancer Inst Monographs, July 1, 2008; 2008(39): 58 - 63. [Abstract] [Full Text] [PDF] C. Homig-Holzel, C. Hojer, J. Rastelli, S. Casola, L. J. Strobl, W. Muller, L. Quintanilla-Martinez, A. Gewies, J. Ruland, K. Rajewsky, et al. Constitutive CD40 signaling in B cells selectively activates the noncanonical NF-{kappa}B pathway and promotes lymphomagenesis J. Exp. Med., June 9, 2008; 205(6): 1317 - 1329. [Abstract] [Full Text] [PDF] K. Bessette, M. L. Lang, R. A. Fava, M. Grundy, J. Heinen, L. Horne, R. Spolski, A. Al-Shami, H. C. Morse III, W. J. Leonard, et al. A Stat5b transgene is capable of inducing CD8+ lymphoblastic lymphoma in the absence of normal TCR/MHC signaling Blood, January 1, 2008; 111(1): 344 - 350. [Abstract] [Full Text] [PDF] H. L. Armata, D. S. Garlick, and H. K. Sluss The Ataxia Telangiectasia Mutated Target Site Ser18 Is Required for p53-Mediated Tumor Suppression Cancer Res., December 15, 2007; 67(24): 11696 - 11703. [Abstract] [Full Text] [PDF] V. Truffinet, E. Pinaud, N. Cogne, B. Petit, L. Guglielmi, M. Cogne, and Y. Denizot The 3' IgH Locus Control Region Is Sufficient to Deregulate a c-myc Transgene and Promote Mature B Cell Malignancies with a Predominant Burkitt-Like Phenotype J. Immunol., November 1, 2007; 179(9): 6033 - 6042. [Abstract] [Full Text] [PDF] D. Caudell, Z. Zhang, Y. J. Chung, and P. D. Aplan Expression of a CALM-AF10 Fusion Gene Leads to Hoxa Cluster Overexpression and Acute Leukemia in Transgenic Mice Cancer Res., September 1, 2007; 67(17): 8022 - 8031. [Abstract] [Full Text] [PDF] B. Zhang, Z. Wang, T. Li, E. N. Tsitsikov, and H.-F. Ding NF-{kappa}B2 mutation targets TRAF1 to induce lymphomagenesis Blood, July 15, 2007; 110(2): 743 - 751. [Abstract] [Full Text] [PDF] E. S. Raveche, E. Salerno, B. J. Scaglione, V. Manohar, F. Abbasi, Y.-C. Lin, T. Fredrickson, P. Landgraf, S. Ramachandra, K. Huppi, et al. Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice Blood, June 15, 2007; 109(12): 5079 - 5086. [Abstract] [Full Text] [PDF] C. Slape, H. Hartung, Y.-W. Lin, J. Bies, L. Wolff, and P. D. Aplan Retroviral Insertional Mutagenesis Identifies Genes that Collaborate with NUP98-HOXD13 during Leukemic Transformation Cancer Res., June 1, 2007; 67(11): 5148 - 5155. [Abstract] [Full Text] [PDF] M. M. Zangani, M. Froyland, G. Y. Qiu, L. A. Meza-Zepeda, J. L. Kutok, K. M. Thompson, L. A. Munthe, and B. Bogen Lymphomas can develop from B cells chronically helped by idiotype-specific T cells J. Exp. Med., May 14, 2007; 204(5): 1181 - 1191. [Abstract] [Full Text] [PDF] S. Kunder, J. Calzada-Wack, G. Holzlwimmer, J. Muller, C. Kloss, W. Howat, J. Schmidt, H. Hofler, M. Warren, and L. Quintanilla-Martinez A Comprehensive Antibody Panel for Immunohistochemical Analysis of Formalin-Fixed, Paraffin-Embedded Hematopoietic Neoplasms of Mice: Analysis of Mouse Specific and Human Antibodies Cross-Reactive with Murine Tissue Toxicol Pathol, April 1, 2007; 35(3): 366 - 375. [Abstract] [Full Text] [PDF] C.-F. Qi, J. X. Zhou, C. H. Lee, Z. Naghashfar, S. Xiang, A. L. Kovalchuk, T. N. Fredrickson, J. W. Hartley, D. C. Roopenian, W. F. Davidson, et al. Anaplastic, Plasmablastic, and Plasmacytic Plasmacytomas of Mice: Relationships to Human Plasma Cell Neoplasms and Late-Stage Differentiation of Normal B Cells Cancer Res., March 15, 2007; 67(6): 2439 - 2447. [Abstract] [Full Text] [PDF] I. R. Matei, R. A. Gladdy, L. M. J. Nutter, A. Canty, C. J. Guidos, and J. S. Danska ATM deficiency disrupts Tcra locus integrity and the maturation of CD4+CD8+ thymocytes Blood, March 1, 2007; 109(5): 1887 - 1896. [Abstract] [Full Text] [PDF] O. S. Kustikova, H. Geiger, Z. Li, M. H. Brugman, S. M. Chambers, C. A. Shaw, K. Pike-Overzet, D. d. Ridder, F. J. T. Staal, G. v. Keudell, et al. Retroviral vector insertion sites associated with dominant hematopoietic clones mark "stemness" pathways Blood, March 1, 2007; 109(5): 1897 - 1907. [Abstract] [Full Text] [PDF] R. D. Cardiff, M. R. Anver, G. P. Boivin, M. W. Bosenberg, R. R. Maronpot, A. A. Molinolo, A. Y. Nikitin, J. E. Rehg, G. V. Thomas, R. G. Russell, et al. Precancer in Mice: Animal Models Used to Understand, Prevent, and Treat Human Precancers Toxicol Pathol, October 1, 2006; 34(6): 699 - 707. [Abstract] [Full Text] [PDF] S. Hassler, C. Ramsey, M. C. Karlsson, D. Larsson, B. Herrmann, B. Rozell, M. Backheden, L. Peltonen, O. Kampe, and O. Winqvist Aire-deficient mice develop hematopoetic irregularities and marginal zone B-cell lymphoma Blood, September 15, 2006; 108(6): 1941 - 1948. [Abstract] [Full Text] [PDF] R. R. Shen, D. O. Ferguson, M. Renard, K. K. Hoyer, U. Kim, X. Hao, F. W. Alt, R. G. Roeder, H. C. Morse III, and M. A. Teitell Dysregulated TCL1 requires the germinal center and genome instability for mature B-cell transformation Blood, September 15, 2006; 108(6): 1991 - 1998. [Abstract] [Full Text] [PDF] R. R. Maronpot A Monograph on Histomorphologic Evaluation of Lymphoid Organs Toxicol Pathol, August 1, 2006; 34(5): 407 - 408. [Full Text] [PDF] S. A. Elmore Histopathology of the Lymph Nodes Toxicol Pathol, August 1, 2006; 34(5): 425 - 454. [Abstract] [Full Text] [PDF] A. W. Suttie Histopathology of the Spleen Toxicol Pathol, August 1, 2006; 34(5): 466 - 503. [Abstract] [Full Text] [PDF] W. Chen, Q. Li, W. A. Hudson, A. Kumar, N. Kirchhof, and J. H. Kersey A murine Mll-AF4 knock-in model results in lymphoid and myeloid deregulation and hematologic malignancy Blood, July 15, 2006; 108(2): 669 - 677. [Abstract] [Full Text] [PDF] V. Voisin, C. Barat, T. Hoang, and E. Rassart Novel insights into the pathogenesis of the graffi murine leukemia retrovirus. J. Virol., April 1, 2006; 80(8): 4026 - 4037. [Abstract] [Full Text] [PDF] M. Fedele, V. Fidanza, S. Battista, F. Pentimalli, A. J.P. Klein-Szanto, R. Visone, I. De Martino, A. Curcio, C. Morisco, L. Del Vecchio, et al. Haploinsufficiency of the hmga1 gene causes cardiac hypertrophy and myelo-lymphoproliferative disorders in mice. Cancer Res., March 1, 2006; 66(5): 2536 - 2543. [Abstract] [Full Text] [PDF] C. H. Lee, M. Melchers, H. Wang, T. A. Torrey, R. Slota, C.-F. Qi, J. Y. Kim, P. Lugar, H. J. Kong, L. Farrington, et al. Regulation of the germinal center gene program by interferon (IFN) regulatory factor 8/IFN consensus sequence-binding protein J. Exp. Med., January 23, 2006; 203(1): 63 - 72. [Abstract] [Full Text] [PDF] S. Z. Glud, A. B. Sorensen, M. Andrulis, B. Wang, E. Kondo, R. Jessen, L. Krenacs, E. Stelkovics, M. Wabl, E. Serfling, et al. A tumor-suppressor function for NFATc3 in T-cell lymphomagenesis by murine leukemia virus Blood, November 15, 2005; 106(10): 3546 - 3552. [Abstract] [Full Text] [PDF] S. S. Park, A. L. Shaffer, J. S. Kim, W. duBois, M. Potter, L. M. Staudt, and S. Janz Insertion of Myc into Igh Accelerates Peritoneal Plasmacytomas in Mice Cancer Res., September 1, 2005; 65(17): 7644 - 7652. [Abstract] [Full Text] [PDF] Y.-W. Lin, R. Deveney, M. Barbara, N. N. Iscove, S. D. Nimer, C. Slape, and P. D. Aplan OLIG2 (BHLHB1), a bHLH Transcription Factor, Contributes to Leukemogenesis in Concert with LMO1 Cancer Res., August 15, 2005; 65(16): 7151 - 7158. [Abstract] [Full Text] [PDF] S. Fujimura, Y. Xing, M. Takeya, Y. Yamashita, K. Ohshima, K. Kuwahara, and N. Sakaguchi Increased Expression of Germinal Center-Associated Nuclear Protein RNA-Primase Is Associated with Lymphomagenesis Cancer Res., July 1, 2005; 65(13): 5925 - 5934. [Abstract] [Full Text] [PDF] Y.-W. Lin, C. Slape, Z. Zhang, and P. D. Aplan NUP98-HOXD13 transgenic mice develop a highly penetrant, severe myelodysplastic syndrome that progresses to acute leukemia Blood, July 1, 2005; 106(1): 287 - 295. [Abstract] [Full Text] [PDF] U. Modlich, O. S. Kustikova, M. Schmidt, C. Rudolph, J. Meyer, Z. Li, K. Kamino, N. von Neuhoff, B. Schlegelberger, K. Kuehlcke, et al. Leukemias following retroviral transfer of multidrug resistance 1 (MDR1) are driven by combinatorial insertional mutagenesis Blood, June 1, 2005; 105(11): 4235 - 4246. [Abstract] [Full Text] [PDF] S. S. Park, J. S. Kim, L. Tessarollo, J. D. Owens, L. Peng, S. S. Han, S. Tae Chung, T. A. Torrey, W. C. Cheung, R. D. Polakiewicz, et al. Insertion of c-Myc into Igh Induces B-Cell and Plasma-Cell Neoplasms in Mice Cancer Res., February 15, 2005; 65(4): 1306 - 1315. [Abstract] [Full Text] [PDF] K. D. Sorensen, L. Quintanilla-Martinez, S. Kunder, J. Schmidt, and F. S. Pedersen Mutation of All Runx (AML1/Core) Sites in the Enhancer of T-Lymphomagenic SL3-3 Murine Leukemia Virus Unmasks a Significant Potential for Myeloid Leukemia Induction and Favors Enhancer Evolution toward Induction of Other Disease Patterns J. Virol., December 1, 2004; 78(23): 13216 - 13231. [Abstract] [Full Text] [PDF] J. M. Zapata, M. Krajewska, H. C. Morse III, Y. Choi, and J. C. Reed TNF receptor-associated factor (TRAF) domain and Bcl-2 cooperate to induce small B cell lymphoma/chronic lymphocytic leukemia in transgenic mice PNAS, November 23, 2004; 101(47): 16600 - 16605. [Abstract] [Full Text] [PDF] B. W. Baron, J. Anastasi, A. Montag, D. Huo, R. M. Baron, T. Karrison, M. J. Thirman, S. K. Subudhi, R. K. Chin, D. W. Felsher, et al. The human BCL6 transgene promotes the development of lymphomas in the mouse PNAS, September 28, 2004; 101(39): 14198 - 14203. [Abstract] [Full Text] [PDF] M. S. Shin, T. N. Fredrickson, J. W. Hartley, T. Suzuki, K. Agaki, and H. C. Morse III High-Throughput Retroviral Tagging for Identification of Genes Involved in Initiation and Progression of Mouse Splenic Marginal Zone Lymphomas Cancer Res., July 1, 2004; 64(13): 4419 - 4427. [Abstract] [Full Text] [PDF] A. Canela, J. Martin-Caballero, J. M. Flores, and M. A. Blasco Constitutive Expression of Tert in Thymocytes Leads to Increased Incidence and Dissemination of T-Cell Lymphoma in Lck-Tert Mice Mol. Cell. Biol., May 15, 2004; 24(10): 4275 - 4293. [Abstract] [Full Text] [PDF] Y. Xu, T. F. Sumter, R. Bhattacharya, A. Tesfaye, E. J. Fuchs, L. J. Wood, D. L. Huso, and L. M. S. Resar The HMG-I Oncogene Causes Highly Penetrant, Aggressive Lymphoid Malignancy in Transgenic Mice and Is Overexpressed in Human Leukemia Cancer Res., May 15, 2004; 64(10): 3371 - 3375. [Abstract] [Full Text] [PDF] M. A. Teitell T cells in mouse follicular lymphoma Blood, March 15, 2004; 103(6): 1981 - 1982. [Full Text] [PDF] A. Egle, A. W. Harris, M. L. Bath, L. O'Reilly, and S. Cory VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia Blood, March 15, 2004; 103(6): 2276 - 2283. [Abstract] [Full Text] [PDF] R. J. Greenwald, J. R. Tumang, A. Sinha, N. Currier, R. D. Cardiff, T. L. Rothstein, D. V. Faller, and G. V. Denis E{micro}-BRD2 transgenic mice develop B-cell lymphoma and leukemia Blood, February 15, 2004; 103(4): 1475 - 1484. [Abstract] [Full Text] [PDF] E. W. Verschuren, J. G. Hodgson, J. W. Gray, S. Kogan, N. Jones, and G. I. Evan The Role of p53 in Suppression of KSHV Cyclin-induced Lymphomagenesis Cancer Res., January 15, 2004; 64(2): 581 - 589. [Abstract] [Full Text] [PDF] P. N. Schofield, J. B. L. Bard, C. Booth, J. Boniver, V. Covelli, P. Delvenne, M. Ellender, W. Engstrom, W. Goessner, M. Gruenberger, et al. Pathbase: a database of mutant mouse pathology Nucleic Acids Res., January 1, 2004; 32(90001): D512 - 515. [Abstract] [Full Text] [PDF] A. M. Ranger, J. Zha, H. Harada, S. R. Datta, N. N. Danial, A. P. Gilmore, J. L. Kutok, M. M. Le Beau, M. E. Greenberg, and S. J. Korsmeyer Bad-deficient mice develop diffuse large B cell lymphoma PNAS, August 5, 2003; 100(16): 9324 - 9329. [Abstract] [Full Text] [PDF] V. Franco, A. M. Florena, and E. Iannitto Splenic marginal zone lymphoma Blood, April 1, 2003; 101(7): 2464 - 2472. [Abstract] [Full Text] [PDF] C. Baum, J. Dullmann, Z. Li, B. Fehse, J. Meyer, D. A. Williams, and C. von Kalle Side effects of retroviral gene transfer into hematopoietic stem cells Blood, March 15, 2003; 101(6): 2099 - 2113. [Abstract] [Full Text] [PDF] P. P. L. Chiu, E. Ivakine, S. Mortin-Toth, and J. S. Danska Susceptibility to Lymphoid Neoplasia in Immunodeficient Strains of Nonobese Diabetic Mice Cancer Res., October 15, 2002; 62(20): 5828 - 5834. [Abstract] [Full Text] [PDF] S. C. Kogan, J. M. Ward, M. R. Anver, J. J. Berman, C. Brayton, R. D. Cardiff, J. S. Carter, S. de Coronado, J. R. Downing, T. N. Fredrickson, et al. Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice Blood, June 17, 2002; 100(1): 238 - 245. [Abstract] [Full Text] [PDF]

	Copyright © 2002 by American Society of Hematology         Online ISSN: 1528-0020